NOXA Antibodies

Haschka, Karbon, Soratroi, O'Neill, Luo, Villunger: "MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment." in: Cell death and differentiation, Vol. 27, Issue 8, pp. 2297-2312, (2021) (PubMed).

Yang, Liu, Li, Chen, Zhao, Wei, Qiu, Liu, Zhou, Han, Wu, Ding: "Genome-scale CRISPR screening for potential targets of ginsenoside compound K." in: Cell death & disease, Vol. 11, Issue 1, pp. 39, (2021) (PubMed).

Gallagher, Gunatilake, Beaumont, Sharp, Tiffen, Heinemann, Weninger, Haass, Wilmott, Madore, Ferguson, Rizos, Hersey: "HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma." in: International journal of cancer, Vol. 142, Issue 9, pp. 1926-1937, (2019) (PubMed).

Pilling, Hwang: "Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide." in: The Prostate, Vol. 79, Issue 11, pp. 1347-1359, (2019) (PubMed).

Minieri, De Dominici, Porazzi, Mariani, Spinelli, Rambaldi, Peterson, Porcu, Nevalainen, Calabretta: "Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph+ Acute Lymphoblastic Leukemia." in: Cancer research, Vol. 78, Issue 20, pp. 5793-5807, (2018) (PubMed).

Gonzalez, OPrey, Cardaci, Barthet, Sakamaki, Beaumatin, Roseweir, Gay, Mackay, Malviya, Kania, Ritchie, Baudot, Zunino, Mrowinska, Nixon, Ennis, Hoyle, Millan, McNeish, Sansom, Edwards, Ryan: "Mannose impairs tumour growth and enhances chemotherapy." in: Nature, Vol. 563, Issue 7733, pp. 719-723, (2018) (PubMed).

Antignani, Segal, Simon, Kreitman, Huang, FitzGerald: "Essential role for Bim in mediating the apoptotic and antitumor activities of immunotoxins." in: Oncogene, Vol. 36, Issue 35, pp. 4953-4962, (2017) (PubMed).

Ichikawa, Alves, Pfeiffer, Langa, Hernández-Santana, Suzuki, Prehn, Engel, Henshall: "Deletion of the BH3-only protein Noxa alters electrographic seizures but does not protect against hippocampal damage after status epilepticus in mice." in: Cell death & disease, Vol. 8, Issue 1, pp. e2556, (2017) (PubMed).

Zhang, Huang, ONeill, Pang, Luo: "Bax/Bak activation in the absence of Bid, Bim, Puma, and p53." in: Cell death & disease, Vol. 7, pp. e2266, (2016) (PubMed).

Long, Schoonen, Graczyk, OPrey, Ryan: "p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death." in: Oncogene, (2015) (PubMed).